StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $691.51MP/E –Yield –

Achieve Life Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2019 it was $0.

Annual revenue

PeriodPeriod endValueChange
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–

More Achieve Life Sciences figures

See a number that looks wrong?